<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The MVA pathway is primarily regulated at the level of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR) [
 <xref rid="B1-metabolites-07-00065" ref-type="bibr" class="xref">1</xref>,
 <xref rid="B12-metabolites-07-00065" ref-type="bibr" class="xref">12</xref>], and it is known that HMGR activity regulates the metabolic flux through the MVA pathway and the eventual production of the isoprenoid end-products [
 <xref rid="B13-metabolites-07-00065" ref-type="bibr" class="xref">13</xref>,
 <xref rid="B14-metabolites-07-00065" ref-type="bibr" class="xref">14</xref>]. The scenario seems to be more complex in the case of the MEP pathway. In fact, the MEP pathway can be regulated by several enzymes, including 1-deoxy-
 <span class="sc" xmlns="http://www.w3.org/1999/xhtml">d</span>-xylulose 5-phosphate (DXP) synthase (DXS), DXP reductoisomerase (DXR) [
 <xref rid="B15-metabolites-07-00065" ref-type="bibr" class="xref">15</xref>] and hydroxymethyl-butenyl 4-diphosphate (HMBPP) reductase (HDR) [
 <xref rid="B13-metabolites-07-00065" ref-type="bibr" class="xref">13</xref>,
 <xref rid="B15-metabolites-07-00065" ref-type="bibr" class="xref">15</xref>,
 <xref rid="B16-metabolites-07-00065" ref-type="bibr" class="xref">16</xref>]. 
</p>
